Evidence map›Paper›PMID 30268364›Full record

ArticleDNA repair2018

Fluorescent fusions of the N protein of phage Mu label DNA damage in living cells.

Matthew V Kotlajich, Jun Xia, Yin Zhai, Hsin-Yu Lin, Catherine C Bradley, Xi Shen, Qian Mei, Anthony Z Wang, Erica J Lynn, Chandan Shee and 6 more

Open access · hybridAbstract read
In one paragraph

Article in DNA repair, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Matthew V KotlajichDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas 77030, USA; Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, Texas 77030, USA; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas 77030, USA; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas 77030, USA.
Jun XiaDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas 77030, USA; Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, Texas 77030, USA; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas 77030, USA; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas 77030, USA.
Yin ZhaiDepartment of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, Texas 77030, USA; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas 77030, USA.
Hsin-Yu LinDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas 77030, USA; Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, Texas 77030, USA; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas 77030, USA; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas 77030, USA.
Catherine C BradleyDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas 77030, USA; Medical Scientist Training Program, Baylor College of Medicine, Houston, Texas 77030, USA; Robert and Janice McNair Foundation/McNair Medical Institute M.D./Ph.D. Scholars Program, Baylor College of Medicine, Houston, Texas 77030, USA.
Xi ShenDepartment of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
Qian MeiDan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas 77030, USA; Systems, Synthetic and Physical Biology Program, Rice University, Houston, Texas 77030, USA.
Anthony Z WangDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas 77030, USA; Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, Texas 77030, USA; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas 77030, USA; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas 77030, USA.
Erica J LynnDepartment of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
Chandan SheeDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas 77030, USA; Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, Texas 77030, USA; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas 77030, USA; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas 77030, USA.
Li-Tzu ChenDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas 77030, USA; Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, Texas 77030, USA; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas 77030, USA; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas 77030, USA.
Lei LiDepartment of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
Kyle M MillerDan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas 77030, USA; Department of Molecular Biosciences, Institute for Cellular and Molecular Biology, University of Texas at Austin, Austin, Texas 78712 USA.
Christophe HermanDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas 77030, USA; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas 77030, USA; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas 77030, USA.
P J HastingsDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas 77030, USA; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas 77030, USA.
Susan M RosenbergDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas 77030, USA; Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, Texas 77030, USA; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas 77030, USA; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas 77030, USA; Systems, Synthetic and Physical Biology Program, Rice University, Houston, Texas 77030, USA. Electronic address: smr@bcm.edu.
Baylor College of Medicine · USThe University of Texas MD Anderson Cancer Center · USTexas Medical Center · US

Funding

Tumor BiologyP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · PI DAVID R ROWLEY · 2007 to 2026
$73.9M
Tissue Analysis & Molecular Imaging CoreP30DK056338 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI Geoffrey A Preidis · 2001 to 2026
$28.3M
TRANSGENIC MOUSE MODELS TO STUDY OVARIAN FUNCTIONU54HD007495 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI RICHARDS, JOANNE STEWART · 1998 to 2013
$19.9M
Molecular Noise, Transcription Errors and Heritable Phenotypic ChangeR01GM088653 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI HERMAN, CHRISTOPHE · 2010 to 2019
$3.1M
MUTATIONAL SIGNATURE(S) OF HUMAN GENOMIC REARRANGEMENT MECHANISMSR01GM106373 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI HASTINGS, PHILIP JOHN, LUPSKI, JAMES R. · 2014 to 2022
$3.1M
MOLECULAR MECHANISMS OF STRESS-INDUCED MUTATIONR35GM122598 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI ROSENBERG, SUSAN M · 2017 to 2020
$2.4M
GROWTH AND DIFFERENTIATION IN EUKARYOTEST32HD007495 · NICHD · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI KINTNER, CHRISTOPHER ROBERT · 1995 to 2009
$1.6M
Genetic Framework and Molecular Mechanism of Fanconi AnemiaR01CA190635 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LI, LEI · 2015 to 2018
$1.5M
TRANSGENIC ANIMAL--COREP30HD007495 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI GLASSER, STANLEY R · 1985 to 1997
–
NCI NIH HHS P30 CA125123NCI NIH HHS R01 CA190635NICHD NIH HHS P30 HD007495NICHD NIH HHS T32 HD007495NIDDK NIH HHS P30 DK056338NIGMS NIH HHS R01 GM088653NIGMS NIH HHS R01 GM106373NIGMS NIH HHS R35 GM122598
6 · The paper itself

Abstract

The N protein of phage Mu was indicated from studies in Escherichia coli to hold linear Mu chromosomes in a circular conformation by non-covalent association, and thus suggested potentially to bind DNA double-stranded ends. Because of its role in association with linear Mu DNA, we tested whether fluorescent-protein fusions to N might provide a useful tool for labeling DNA damage including double-strand break (DSB) ends in single cells. We compared N-GFP with a biochemically well documented DSB-end binding protein, the Gam protein of phage Mu, also fused to GFP. We find that N-GFP produced in live E. coli forms foci in response to DNA damage induced by radiomimetic drug phleomycin, indicating that it labels damaged DNA. N-GFP also labels specific DSBs created enzymatically by I-SceI double-strand endonuclease, and by X-rays, with the numbers of foci corresponding with the numbers of DSBs generated, indicating DSB labeling. However, whereas N-GFP forms about half as many foci as GamGFP with phleomycin, its labeling of I-SceI- and X-ray-induced DSBs is far less efficient than that of GamGFP. The data imply that N-GFP binds and labels DNA damage including DSBs, but may additionally label phleomycin-induced non-DSB damage, with which DSB-specific GamGFP does not interact. The data indicate that N-GFP labels DNA damage, and may be useful for general, not DSB-specific, DNA-damage detection.

Indexed as

DNA DamageBacteriophage muDNA Breaks, Double-StrandedEscherichia coliExonucleasesFluorescent DyesPhleomycinsViral Regulatory and Accessory ProteinsExonucleasesFluorescent DyesPhleomycinsViral Regulatory and Accessory ProteinsDNA damageDouble-strand breaksEscherichia coliPhage Mu N proteinPhleomycinRecBCDSingle-cell analysis

Identifiers

PMID30268364
PMCPMC6287932
OpenAlexW2890954612

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.